You are on page 1of 2

DIAGNOSTIC REPORT

MC-5746

PATIENT NAME : RITIKA PATHAK REF. DOCTOR : DR. A BARUA


CODE/NAME & ADDRESS : C000078980 ACCESSION NO : 0031XC003439 AGE/SEX : 21 Years Female
PARK VIEW SPECIALITY HOSPITAL UNIT OF PATIENT ID : RITIF04030331 DRAWN : 04/03/2024 00:00:00
ANKUSH MEDICARE PVT
HB 36-A/4-36/A/5/1, LT
SECTOR - 3 SALTLAKE,
CLIENT PATIENT ID: RECEIVED : 04/03/2024 14:40:15
KOLKATA 700106
ABHA NO : REPORTED : 04/03/2024 16:20:45
33-40591111 7003190814

Test Report Status Final Results Biological Reference Interval Units

ALLERGY
TOTAL IGE, SERUM
TOTAL IGE 460.5 High < 100 IU/mL
METHOD : IMMUNOTURBIDIMETRIC ASSAY

<b>Interpretation(s)</b>
TOTAL IGE, SERUM-Introduction:
Total Immunoglobulin (IgE), serum measures the total quantity of circulating IgE in human serum samples. Immunoglobulin E (IgE) is one of the 5 classes of
immunoglobulins and is defined by the presence of the epsilon heavy chain.

Test Utility:
Elevated levels may be found in,
1.Allergy - IgE antibodies appear as a result of sensitization to allergens, and the measurement of circulating total IgE assists the clinical diagnosis of IgE-mediated
allergic disorders. Elevated levels of circulating total IgE are usually seen in atopic eczema, 60% of patients with extrinsic asthma, and about 30% cases of hay fever.
However a markedly elevated total IgE may bind non-specifically with allergen solid phase and result in weakly positive specific IgE that may not be clinically relevant.
2. Parasitic infestations - Ascariasis, Visceral larva migrans, Hookworm disease, Schistosomiasis, Echinococcosis.
3. Monoclonal IgE myeloma
4. Allergic Bronchopulmonary Aspergillosis (ABPA)

Decreased levels may be found in,


1. Hereditary deficiencies
2. Acquired immunodeficiency
3. Ataxia telangiaectasia
4. Non-secretory myeloma
Limitation:
A normal level of IgE does not eliminate the possibility of allergy, hence test is not recommended as a stand-alone screen. Value is influenced by type of allergen,
duration of stimulation, presence of symptoms, hyposensitization treatment.

**End Of Report**
Please visit www.agilusdiagnostics.com for related Test Information for this accession

Page 1 Of 2

Dr. Chaitali Ray, PHD


Chief Biochemist cum MRQA

View Details View Report


PERFORMED AT :
Agilus Diagnostics Ltd.
P S Srijan Tech Park Building, Dn-52, Unit No. 2, Ground Floor, Sector V, Salt Lake,
Kolkata, 700091 Patient Ref. No. 31000004944066
West Bengal, India
Tel : 9111591115, Fax : 30203412
CIN - U74899PB1995PLC045956
Email : customercare.saltlake@agilus.in
DIAGNOSTIC REPORT

MC-5746

PATIENT NAME : RITIKA PATHAK REF. DOCTOR : DR. A BARUA


CODE/NAME & ADDRESS : C000078980 ACCESSION NO : 0031XC003439 AGE/SEX : 21 Years Female
PARK VIEW SPECIALITY HOSPITAL UNIT OF PATIENT ID : RITIF04030331 DRAWN : 04/03/2024 00:00:00
ANKUSH MEDICARE PVT
HB 36-A/4-36/A/5/1, LT
SECTOR - 3 SALTLAKE,
CLIENT PATIENT ID: RECEIVED : 04/03/2024 14:40:15
KOLKATA 700106
ABHA NO : REPORTED : 04/03/2024 16:20:45
33-40591111 7003190814

Test Report Status Final Results Biological Reference Interval Units

CONDITIONS OF LABORATORY TESTING & REPORTING


1. It is presumed that the test sample belongs to the patient 5. AGILUS Diagnostics confirms that all tests have been
named or identified in the test requisition form. performed or assayed with highest quality standards,
2. All tests are performed and reported as per the clinical safety & technical integrity.
turnaround time stated in the AGILUS Directory of Services. 6. Laboratory results should not be interpreted in
3. Result delays could occur due to unforeseen isolation; it must be correlated with clinical information and
circumstances such as non-availability of kits / equipment be interpreted by registered medical practitioners only to
breakdown / natural calamities / technical downtime or any determine final diagnosis.
other unforeseen event. 7. Test results may vary based on time of collection,
4. A requested test might not be performed if: physiological condition of the patient, current medication or
i. Specimen received is insufficient or inappropriate nutritional and dietary changes. Please consult your doctor
ii. Specimen quality is unsatisfactory or call us for any clarification.
iii. Incorrect specimen type 8. Test results cannot be used for Medico legal purposes.
iv. Discrepancy between identification on specimen 9. In case of queries please call customer care
container label and test requisition form (91115 91115) within 48 hours of the report.
.
Agilus Diagnostics Ltd
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062

Page 2 Of 2

Dr. Chaitali Ray, PHD


Chief Biochemist cum MRQA

View Details View Report


PERFORMED AT :
Agilus Diagnostics Ltd.
P S Srijan Tech Park Building, Dn-52, Unit No. 2, Ground Floor, Sector V, Salt Lake,
Kolkata, 700091 Patient Ref. No. 31000004944066
West Bengal, India
Tel : 9111591115, Fax : 30203412
CIN - U74899PB1995PLC045956
Email : customercare.saltlake@agilus.in

You might also like